186 related articles for article (PubMed ID: 15197886)
1. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
Kaizu K; Uriu K; Ikeda M
Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
[No Abstract] [Full Text] [Related]
2. Extracorporeal anticoagulation using a serine protease inhibitor in hemodialysis in sheep.
Mottaghy K; Oedekoven B; Bey R; Schmid-Schönbein H
Trans Am Soc Artif Intern Organs; 1985; 31():534-6. PubMed ID: 3939276
[No Abstract] [Full Text] [Related]
3. [Anticoagulation for plasmapheresis].
Amemiya H; Sekihara H; Kobayashi T; Koiwa F; Niikura K
Nihon Rinsho; 2004 May; 62 Suppl 5():323-7. PubMed ID: 15197938
[No Abstract] [Full Text] [Related]
4. [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].
Vukusich A; Avalos C; Orellana G; Cifuentes C; Rivas J; Calderón F
Rev Med Chil; 1995 Jun; 123(6):735-41. PubMed ID: 8525227
[TBL] [Abstract][Full Text] [Related]
5. The influence of a serine protease inhibitor, nafamostat mesilate, on plasma coagulation, and platelet activation during experimental Extracorporeal Life Support (ECLS).
Mellgren K; Skogby M; Friberg LG; Tengborn L; Wadenvik H
Thromb Haemost; 1998 Feb; 79(2):342-7. PubMed ID: 9493588
[TBL] [Abstract][Full Text] [Related]
6. About the effect of low-molecular-weight heparin on platelet function in haemodialysis patients.
Eleftheriadis T; Antoniadi G; Liakopoulos V; Stefanidis I
Nephrol Dial Transplant; 2009 Mar; 24(3):1063-4. PubMed ID: 19131348
[No Abstract] [Full Text] [Related]
7. [Heparin in surgery and artificial circulation: pro and contra. Is there an alternative?].
Roĭtman EV; Dement'eva II; Meshcheriakov AV
Anesteziol Reanimatol; 1997; (6):65-9. PubMed ID: 9511253
[No Abstract] [Full Text] [Related]
8. [Anticoagulation].
Matsuda O
Nihon Rinsho; 1991 Dec; 49 Suppl():279-86. PubMed ID: 1808269
[No Abstract] [Full Text] [Related]
9. Gabexate mesilate (Foy) as an anticoagulant in extracorporeal circulation in dogs and sheep.
Oedekoven B; Bey R; Mottaghy K; Schmid-Schönbein H
Thromb Haemost; 1984 Dec; 52(3):329-32. PubMed ID: 6442472
[TBL] [Abstract][Full Text] [Related]
10. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
Delsart D; Chambefort V; Decousus H
Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
[No Abstract] [Full Text] [Related]
11. Effects of surface-bound and intravenously administered heparin on cell-surface interactions: inflammation and coagulation.
Johnson G; Curry B; Cahalan L; Prater R; Biggerstaff J; Hussain A; Gartner M; Cahalan P
Perfusion; 2013 May; 28(3):263-71. PubMed ID: 23401339
[TBL] [Abstract][Full Text] [Related]
12. [Application of gabexate mesilate on measurement of coagulation and fibrinolysis. --The effect of high molecular weight Fbg/Fb complex in plasma-- (author's transl)].
Suzuki S; Tahara C; Kazama M
Rinsho Byori; 1981 Apr; 29(4):404-8. PubMed ID: 6798246
[No Abstract] [Full Text] [Related]
13. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
[TBL] [Abstract][Full Text] [Related]
14. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
Heitz J; Semsch B; Emde C; Jansen U; Schäfer JH
Z Gastroenterol; 1990 Apr; 28(4):192-7. PubMed ID: 2119091
[TBL] [Abstract][Full Text] [Related]
15. Contaminated heparin-affected patient plasmas are associated with activated contact systems.
Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Beck AM; Shih FF; Lijuan Zhang
Clin Appl Thromb Hemost; 2010 Jun; 16(3):261-5. PubMed ID: 20547554
[No Abstract] [Full Text] [Related]
16. [How to use anticoagulants in hemodialysis therapy].
Uriu K; Kaizu K
Nihon Rinsho; 2004 May; 62 Suppl 5():163-7. PubMed ID: 15197908
[No Abstract] [Full Text] [Related]
17. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
[TBL] [Abstract][Full Text] [Related]
18. [Beneficial characteristics of protease inhibitor as an anticoagulant for extracorporeal circulation].
Akizawa T
Rinsho Ketsueki; 1990 Jun; 31(6):782-6. PubMed ID: 2214168
[TBL] [Abstract][Full Text] [Related]
19. Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses.
Paparella D; Semeraro F; Scrascia G; Galeone A; Ammollo CT; Kounakis G; de Luca Tupputi Schinosa L; Semeraro N; Colucci M
Ann Thorac Surg; 2010 Feb; 89(2):421-7. PubMed ID: 20103314
[TBL] [Abstract][Full Text] [Related]
20. [Low-dose calcium-heparin prophylaxis in thoracic surgery. Bleeding, changes in coagulation and fibrinolysis].
Marchetti V; Beati C; Pogliani EM; Vincre G
Minerva Med; 1983 Jul; 74(28-29):1745-8. PubMed ID: 6866306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
